---
figid: PMC8360622__IJO-59-03-05253-g00
figtitle: Novel insights into the impact of the SUMOylation pathway in hematological
  malignancies (Review)
organisms:
- Drosophila melanogaster
- Caenorhabditis elegans
- Trypanosoma brucei
- Saccharomyces cerevisiae
- Tripterygium wilfordii
- Homo sapiens
- Mus musculus
- Adenoviridae
pmcid: PMC8360622
filename: IJO-59-03-05253-g00.jpg
figlink: /pmc/articles/PMC8360622/figure/f1-ijo-59-03-05253/
number: F1
caption: SUMO conjugation/deconjugation pathway. Nascent SUMO1-3 precursors are first
  cleaved by the SUMO isopeptidases, SENPs, to expose the carboxy-terminal Gly-Gly
  motif. Then, mature SUMO is activated by the heterodimeric E1 activating enzyme
  SAE1/UBA2, which yields a SUMO/UBA2 high-energy thioester bond in an ATP dependent
  reaction. SUMO is then transferred to the only E2 conjugating enzyme, Ubc9, forming
  another thioester bond. The last enzymatic step requires a specific SUMO E3 ligase
  that facilitates the conjugation of SUMO to a substrate. The target protein can
  be mono-SUMOylated, multi-SUMOylated and poly-SUMOylated. SUMOylation is a reversible
  process, and SUMO can be freed by SENPs into a new cycle. SUMO, small ubiquitin-like
  modifier; SAE1, SUMO1 activating enzyme subunit 1; UBA2, ubiquitin like modifier
  activating enzyme 2; SENP, sentrin/SUMO-specific protease; Ubc9, ubiquitin conjugating
  enzyme E2 I; Gly, glycine.
papertitle: Novel insights into the impact of the SUMOylation pathway in hematological
  malignancies (Review).
reftext: Ling Wang, et al. Int J Oncol. 2021 Sep;59(3):73.
year: '2021'
doi: 10.3892/ijo.2021.5253
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos
keywords: SUMOylation | SUMO enzymes | hematological malignancies | multiple myeloma
automl_pathway: 0.9427068
figid_alias: PMC8360622__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8360622__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8360622__IJO-59-03-05253-g00.html
  '@type': Dataset
  description: SUMO conjugation/deconjugation pathway. Nascent SUMO1-3 precursors
    are first cleaved by the SUMO isopeptidases, SENPs, to expose the carboxy-terminal
    Gly-Gly motif. Then, mature SUMO is activated by the heterodimeric E1 activating
    enzyme SAE1/UBA2, which yields a SUMO/UBA2 high-energy thioester bond in an ATP
    dependent reaction. SUMO is then transferred to the only E2 conjugating enzyme,
    Ubc9, forming another thioester bond. The last enzymatic step requires a specific
    SUMO E3 ligase that facilitates the conjugation of SUMO to a substrate. The target
    protein can be mono-SUMOylated, multi-SUMOylated and poly-SUMOylated. SUMOylation
    is a reversible process, and SUMO can be freed by SENPs into a new cycle. SUMO,
    small ubiquitin-like modifier; SAE1, SUMO1 activating enzyme subunit 1; UBA2,
    ubiquitin like modifier activating enzyme 2; SENP, sentrin/SUMO-specific protease;
    Ubc9, ubiquitin conjugating enzyme E2 I; Gly, glycine.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sumo
  - ATPsynbeta
  - Atpalpha
  - gg
  - Ggamma1
  - Ggamma30A
  - lwr
  - E3
  - Aos1
  - Uba2
  - CG11700
  - qvr
---
